Literature DB >> 19090718

A completed KLK activome profile: investigation of activation profiles of KLK9, 10, and 15.

Hyesook Yoon1, Sachiko I Blaber, Mekdes Debela, Peter Goettig, Isobel A Scarisbrick, Michael Blaber.   

Abstract

We previously reported the activation profiles of the human kallikrein-related peptidases (KLKs) as determined from a KLK pro-peptide fusion-protein system. That report described the activity profiles of 12 of the 15 mature KLKs versus the 15 different pro-KLK sequences. The missing profiles in the prior report, involving KLK9, 10, and 15, are now described. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis, mass spectrometry, and N-terminal sequence analyses show that KLK9 and 10 exhibit low hydrolytic activities towards all of the 15 pro-KLK sequences, while KLK15 exhibits significant activity towards both Arg- and Lys-containing KLK pro-sequences. The ability of KLK15 to activate pro-KLK8, 12, and 14 is confirmed using recombinant pro-KLK proteins, and shown to be significant for activation of pro-KLK8 and 14, but not 12. These additional data for KLK9, 10, and 15 now permit a completed KLK activome profile, using a KLK pro-peptide fusion-protein system, to be described. The results suggest that KLK15, once activated, can potentially feed back into additional pro-KLK activation pathways. Conversely, KLK9 and 10, once activated, are unlikely to participate in further pro-KLK activation pathways, although similar to KLK1 they may activate other bioactive peptides.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19090718      PMCID: PMC2838389          DOI: 10.1515/BC.2009.026

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  41 in total

1.  Human glandular kallikrein 2 expression in prostate adenocarcinoma and lymph node metastases.

Authors:  M F Darson; A Pacelli; P Roche; H G Rittenhouse; R L Wolfert; M S Saeid; C Y Young; G G Klee; D J Tindall; D G Bostwick
Journal:  Urology       Date:  1999-05       Impact factor: 2.649

2.  A comprehensive nomenclature for serine proteases with homology to tissue kallikreins.

Authors:  Ake Lundwall; Vimla Band; Michael Blaber; Judith A Clements; Yves Courty; Eleftherios P Diamandis; Hans Fritz; Hans Lilja; Johan Malm; Lois J Maltais; A Yvonne Olsson; Constantina Petraki; Andreas Scorilas; Georgia Sotiropoulou; Ulf-Håkan Stenman; Carsten Stephan; Maroulio Talieri; George M Yousef
Journal:  Biol Chem       Date:  2006-06       Impact factor: 3.915

3.  Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.

Authors:  T A Stamey; N Yang; A R Hay; J E McNeal; F S Freiha; E Redwine
Journal:  N Engl J Med       Date:  1987-10-08       Impact factor: 91.245

4.  Potential scope of action of tissue kallikreins in CNS immune-mediated disease.

Authors:  I A Scarisbrick; S I Blaber; J T Tingling; M Rodriguez; M Blaber; G P Christophi
Journal:  J Neuroimmunol       Date:  2006-07-07       Impact factor: 3.478

5.  The expanded human kallikrein gene family: locus characterization and molecular cloning of a new member, KLK-L3 (KLK9).

Authors:  G M Yousef; E P Diamandis
Journal:  Genomics       Date:  2000-04-15       Impact factor: 5.736

6.  Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7.

Authors:  Cécile Caubet; Nathalie Jonca; Maria Brattsand; Marina Guerrin; Dominique Bernard; Rainer Schmidt; Torbjörn Egelrud; Michel Simon; Guy Serre
Journal:  J Invest Dermatol       Date:  2004-05       Impact factor: 8.551

7.  Structural role of Gly(193) in serine proteases: investigations of a G555E (GLY193 in chymotrypsin) mutant of blood coagulation factor XI.

Authors:  Amy E Schmidt; Taketoshi Ogawa; David Gailani; S Paul Bajaj
Journal:  J Biol Chem       Date:  2004-04-16       Impact factor: 5.157

8.  Human tissue kallikrein 5 is a member of a proteolytic cascade pathway involved in seminal clot liquefaction and potentially in prostate cancer progression.

Authors:  Iacovos P Michael; Georgios Pampalakis; Stephen D Mikolajczyk; Johan Malm; Georgia Sotiropoulou; Eleftherios P Diamandis
Journal:  J Biol Chem       Date:  2006-03-03       Impact factor: 5.157

Review 9.  Tissue kallikrein proteolytic cascade pathways in normal physiology and cancer.

Authors:  Georgios Pampalakis; Georgia Sotiropoulou
Journal:  Biochim Biophys Acta       Date:  2007-06-14

10.  Expression of kallikrein-related peptidases (KRP/hK5, 7, 6, 8) in subtypes of human lung carcinoma.

Authors:  Jasmine Singh; Anupam Naran; Neil L Misso; Paul J Rigby; Philip J Thompson; Kanti D Bhoola
Journal:  Int Immunopharmacol       Date:  2007-09-06       Impact factor: 4.932

View more
  20 in total

1.  Kallikrein cascades in traumatic spinal cord injury: in vitro evidence for roles in axonopathy and neuron degeneration.

Authors:  Maja Radulovic; Hyesook Yoon; Nadya Larson; Jianmin Wu; Rachel Linbo; Joshua E Burda; Eleftherios P Diamandis; Sachiko I Blaber; Michael Blaber; Michael G Fehlings; Isobel A Scarisbrick
Journal:  J Neuropathol Exp Neurol       Date:  2013-11       Impact factor: 3.685

Review 2.  Unleashing the therapeutic potential of human kallikrein-related serine proteases.

Authors:  Ioannis Prassas; Azza Eissa; Gennadiy Poda; Eleftherios P Diamandis
Journal:  Nat Rev Drug Discov       Date:  2015-02-20       Impact factor: 84.694

3.  Activation profiles of human kallikrein-related peptidases by matrix metalloproteinases.

Authors:  Hyesook Yoon; Sachiko I Blaber; Wu Li; Isobel A Scarisbrick; Michael Blaber
Journal:  Biol Chem       Date:  2013-01       Impact factor: 3.915

Review 4.  Putative functions of tissue kallikrein-related peptidases in vaginal fluid.

Authors:  Carla M J Muytjens; Stella K Vasiliou; Katerina Oikonomopoulou; Ioannis Prassas; Eleftherios P Diamandis
Journal:  Nat Rev Urol       Date:  2016-09-07       Impact factor: 14.432

5.  Toward an integrative analysis of the tumor microenvironment in ovarian epithelial carcinoma.

Authors:  Ryan N Serio
Journal:  Cancer Microenviron       Date:  2011-11-23

Review 6.  Implication of the Kallikrein-Kinin system in neurological disorders: Quest for potential biomarkers and mechanisms.

Authors:  Amaly Nokkari; Hadi Abou-El-Hassan; Yehia Mechref; Stefania Mondello; Mark S Kindy; Ayad A Jaffa; Firas Kobeissy
Journal:  Prog Neurobiol       Date:  2018-01-31       Impact factor: 11.685

7.  Advanced high-grade serous ovarian cancer: inverse association of KLK13 and KLK14 mRNA levels in tumor tissue and patients' prognosis.

Authors:  Larissa Dettmar; Nancy Ahmed; Matthias Kotzsch; Sandra Diersch; Rudolf Napieralski; Dalila Darmoul; Manfred Schmitt; Wilko Weichert; Marion Kiechle; Julia Dorn; Viktor Magdolen
Journal:  J Cancer Res Clin Oncol       Date:  2018-03-15       Impact factor: 4.553

8.  Stability of [-2]Pro-PSA in whole blood and serum: analysis for optimal measurement conditions.

Authors:  Tsukasa Igawa; Kosuke Takehara; Toru Onita; Kazuto Ito; Hideki Sakai
Journal:  J Clin Lab Anal       Date:  2014-02-27       Impact factor: 2.352

Review 9.  Functional roles of human kallikrein-related peptidases.

Authors:  Georgia Sotiropoulou; Georgios Pampalakis; Eleftherios P Diamandis
Journal:  J Biol Chem       Date:  2009-10-09       Impact factor: 5.157

10.  Kallikrein 6 regulates early CNS demyelination in a viral model of multiple sclerosis.

Authors:  Isobel A Scarisbrick; Hyesook Yoon; Michael Panos; Nadya Larson; Sachiko I Blaber; Michael Blaber; Moses Rodriguez
Journal:  Brain Pathol       Date:  2012-03-21       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.